NCT00207675 – A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNF a Chimeric Monoclonal Antibody (Infliximab, REMICADE) in Pediatric Subjects With Moderate to Severe CROHN’S Disease Posted on September 22, 2014 by tsuperadmin -
NCT00096655 – A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis Posted on September 22, 2014 by tsuperadmin -
NCT00036439 – A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis Posted on September 22, 2014 by tsuperadmin -
The YODA Project